Does PALIVIZUMAB Cause Ventricular septal defect? 17 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Ventricular septal defect have been filed in association with PALIVIZUMAB (Synagis). This represents 0.2% of all adverse event reports for PALIVIZUMAB.
17
Reports of Ventricular septal defect with PALIVIZUMAB
0.2%
of all PALIVIZUMAB reports
2
Deaths
10
Hospitalizations
How Dangerous Is Ventricular septal defect From PALIVIZUMAB?
Of the 17 reports, 2 (11.8%) resulted in death, 10 (58.8%) required hospitalization, and 1 (5.9%) were considered life-threatening.
Is Ventricular septal defect Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PALIVIZUMAB. However, 17 reports have been filed with the FAERS database.
What Other Side Effects Does PALIVIZUMAB Cause?
Respiratory syncytial virus infection (1,692)
Pyrexia (1,055)
Death (856)
Bronchiolitis (724)
Cough (665)
Pneumonia (657)
Dyspnoea (466)
Nasopharyngitis (462)
Vomiting (445)
Influenza (398)
What Other Drugs Cause Ventricular septal defect?
ONDANSETRON (301)
LAMOTRIGINE (238)
PAROXETINE (225)
SERTRALINE (193)
LEVETIRACETAM (172)
FLUOXETINE (171)
CITALOPRAM HYDROBROMIDE (158)
VENLAFAXINE (152)
ASPIRIN (146)
RAMIPRIL (145)
Which PALIVIZUMAB Alternatives Have Lower Ventricular septal defect Risk?
PALIVIZUMAB vs PALONOSETRON
PALIVIZUMAB vs PAMIDRONATE
PALIVIZUMAB vs PAMIDRONIC ACID
PALIVIZUMAB vs PANCRELIPASE
PALIVIZUMAB vs PANCRELIPASE AMYLASE\PANCRELIPASE LIPASE\PANCRELIPASE PROTEASE